Tracking the implementation of NCCLS M100-S12 expanded-spectrum cephalosporin MIC breakpoints for nonmeningeal isolates of Streptococcus pneumoniae by clinical laboratories in the United States during 2002 and 2003
Open Access
- 1 January 2004
- journal article
- research article
- Published by Springer Nature in Annals of Clinical Microbiology and Antimicrobials
- Vol. 3 (1) , 1
- https://doi.org/10.1186/1476-0711-3-1
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Impact of Modified Nonmeningeal Streptococcus pneumoniae Interpretive Criteria (NCCLS M100-S12) on the Susceptibility Patterns of Five Parenteral Cephalosporins: Report from the SENTRY Antimicrobial Surveillance Program (1997 to 2001)Journal of Clinical Microbiology, 2002
- In Vitro Activities of Broad-Spectrum Cephalosporins against Nonmeningeal Isolates of Streptococcus pneumoniae : MIC Interpretation Using NCCLS M100-S12 RecommendationsJournal of Clinical Microbiology, 2002
- Antimicrobial Resistance in Key Bloodstream Bacterial Isolates: Electronic Surveillance with The Surveillance Network Database‐‐USAClinical Infectious Diseases, 1999